B-Cell Malignancies
Showing 1 - 10 of 10
B-Cell Malignancies Trial (TT-01488 Tablets)
Not yet recruiting
- B-Cell Malignancies
- TT-01488 Tablets
- (no location specified)
Jan 4, 2023
B-cell Malignancies Trial in Australia (Zanubrutinib, Fluconazole, Diltiazem)
Completed
- B-cell Malignancies
- Zanubrutinib
- +4 more
-
Concord, New South Wales, Australia
- +6 more
Jul 18, 2022
B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),
Completed
- B-cell Malignancies
- +7 more
- Nivolumab (Phase 1)
- +4 more
-
Birmingham, Alabama
- +23 more
Aug 26, 2020
B-cell Malignancies, Cancer Trial in Worldwide (MEDI-551, Rituximab)
Completed
- B-cell Malignancies
- Cancer
-
Birmingham, Alabama
- +20 more
Apr 29, 2020
Influenza Vaccine in B-cell Malignancies Treated With Idelalisib
Terminated
- B-cell Malignancies
- Influenza Vaccine
-
Prague 10, Czechia
- +1 more
Feb 18, 2020
B-cell Malignancies Trial in Shenzhen, Kunming (Therapeutic 4SCAR19 cells)
Unknown status
- B-cell Malignancies
- Therapeutic 4SCAR19 cells
-
Shenzhen, Guangdong, China
- +1 more
Sep 18, 2019
B-cell Malignancies Trial in Guangzhou, Shenzhen, Kunming (4SCAR19 and 4SCAR22, 4SCAR19 and 4SCAR38, 4SCAR19 and 4SCAR20)
Unknown status
- B-cell Malignancies
- 4SCAR19 and 4SCAR22
- +5 more
-
Guangzhou, Guangdong, China
- +3 more
Sep 18, 2019
B-Cell Malignancies Trial (Low dose ET019002- T Cells, Middle dose ET019002- T Cells, High dose ET019002- T Cells)
Unknown status
- B-Cell Malignancies
- Low dose ET019002- T Cells
- +2 more
- (no location specified)
Aug 22, 2018
B-Cell Malignancies Trial in United States (Urelumab, Rituximab)
Completed
- B-Cell Malignancies
- Urelumab
- Rituximab
-
Los Angeles, California
- +14 more
Mar 29, 2017